GLP1 Receptor Agonist Liraglutide Is an Effective Therapeutic Option for Perioperative Glycemic Control in Type 2 Diabetes within Enhanced Recovery After Surgery (ERAS) Protocols.

Kaneko, Shizuka; Ueda, Youhei; Tahara, Yumiko

Kaneko, Shizuka; Ueda, Youhei; Tahara, Yumiko.

Affiliation

Kaneko S; Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan, skayamoe@takatsuki.jrc.or.jp.
Ueda Y; Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan.
Tahara Y; Division of Diabetes/Endocrinology/Lifestyle-Related Disease, Takatsuki Red Cross Hospital, Takatsuki, Japan.

Eur Surg Res ; 59(5-6): 349-360, 2018.

Article in En | MEDLINE | ID: mdl-30537714

Subject(s)

Blood Glucose/analysis; Diabetes Mellitus, Type 2/drug therapy; Glucagon-Like Peptide 1/agonists; Liraglutide/therapeutic use; Perioperative Care; Postoperative Complications/prevention & control; Aged; Aged, 80 and over; Clinical Protocols; Diabetes Mellitus, Type 2/blood; Female; Humans; Male; Middle Aged; Recovery of Function

Key words

ERAS; Glucagon-like peptide-1 receptor agonists; Glycemic control; Type 2 diabetes

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Blood Glucose / Perioperative Care / Diabetes Mellitus, Type 2 / Glucagon-Like Peptide 1 / Liraglutide Type of study: Clinical_trials / Guideline Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur Surg Res Year: 2018 Document type: Article Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google